Atinumab

Atinumab
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T82947-1mg 1 mg

5 - 10 business days*

183.00€
TGM-T82947-5mg 5 mg

5 - 10 business days*

456.00€
TGM-T82947-10mg 10 mg - - -

5 - 10 business days*

654.00€
TGM-T82947-25mg 25 mg - - -

5 - 10 business days*

1,023.00€
TGM-T82947-50mg 50 mg - - -

5 - 10 business days*

1,412.00€
 
Description: Atinumab (6A3-IgG4) is a monoclonal antibody inhibitor targeting reticulon-4 (Nogo)... more
Product information "Atinumab"
Description: Atinumab (6A3-IgG4) is a monoclonal antibody inhibitor targeting reticulon-4 (Nogo) that stimulates the growth of neural protrusions and has immunomodulatory activity. Target: Others. References: Kucher K, Johns D, Maier D, Abel R, Badke A, Baron H, Thietje R, Casha S, Meindl R, Gomez-Mancilla B, Pfister C, Rupp R, Weidner N, Mir A, Schwab ME, Curt A. First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury. Neurorehabil Neural Repair. 2018 Jun,32(6-7):578-589.
Keywords: ATI355 , ATI 355 , 6A3-IgG4
Supplier: TargetMol
Supplier-Nr: T82947

Properties

Conjugate: No

Database Information

CAS : 1226761-65-4| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Atinumab"
Write a review
or to review a product.
Viewed